ProRx Pharma Continues to Grow Operational Footprint, Triples Production Capacity to Support Demand for Compounded Medications
Facility Expansion, Automation Investments, and Workforce Additions Drive Growth EXTON, Pa., April 21, 2026 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced a period of significant growth, including increased production capacity, a...
View original →